Evidence map›Paper›PMID 42003960›Full record

ArticleInfection and drug resistance2026

Genomic Characterization of Antibiotic-Resistant

Hong Yu, Peng Xiong, HuiNa Zhang, Zhi Lu, XinLu Chen, RuHua Yan, Lei Wang, Long Yu, Qingyong Zhang, Lili Zou and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection and drug resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hong YuDepartment of Medical Ultrasound, Tongji Hospital, Tongji Medical College, and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, People's Republic of China.
Peng XiongHubei Key Laboratory of Tumor Microenvironment and Immunotherapy, College of Basic Medical Sciences, China Three Gorges University, Yichang, Hubei, 443002, People's Republic of China.
HuiNa ZhangHubei Key Laboratory of Tumor Microenvironment and Immunotherapy, College of Basic Medical Sciences, China Three Gorges University, Yichang, Hubei, 443002, People's Republic of China.
Zhi LuHubei Key Laboratory of Tumor Microenvironment and Immunotherapy, College of Basic Medical Sciences, China Three Gorges University, Yichang, Hubei, 443002, People's Republic of China.
XinLu ChenHubei Key Laboratory of Tumor Microenvironment and Immunotherapy, College of Basic Medical Sciences, China Three Gorges University, Yichang, Hubei, 443002, People's Republic of China.
RuHua YanHubei Key Laboratory of Tumor Microenvironment and Immunotherapy, College of Basic Medical Sciences, China Three Gorges University, Yichang, Hubei, 443002, People's Republic of China.
Lei WangHubei Key Laboratory of Tumor Microenvironment and Immunotherapy, College of Basic Medical Sciences, China Three Gorges University, Yichang, Hubei, 443002, People's Republic of China.
Long YuHubei Key Laboratory of Tumor Microenvironment and Immunotherapy, College of Basic Medical Sciences, China Three Gorges University, Yichang, Hubei, 443002, People's Republic of China.
Qingyong ZhangThe First College of Clinical Medical Science, China Three Gorges University, Yichang, Hubei, 443002, People's Republic of China.
Lili ZouHubei Key Laboratory of Tumor Microenvironment and Immunotherapy, College of Basic Medical Sciences, China Three Gorges University, Yichang, Hubei, 443002, People's Republic of China.ORCID 0000-0003-1393-0971
Lu WangHubei Key Laboratory of Tumor Microenvironment and Immunotherapy, College of Basic Medical Sciences, China Three Gorges University, Yichang, Hubei, 443002, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Antimicrobial-resistant Methods: Between February 2023 and December 2024, 150 antibiotic-resistant Results: Conclusion: Our findings demonstrate that whole-genome sequencing is not only a powerful tool for characterizing dominant epidemic clones but also an effective strategy for surveillance of atypical and emerging

Indexed as

antimicrobial-resistant Enterococcusmultilocus sequence typingresistance genevirulence genewhole-genome sequencing

Identifiers

PMID42003960
PMCPMC13091595

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.